Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Istari Oncology
AddedFeb 17, 2024
UpdatedJun 18, 2026
Istari Oncology

Istari Oncology

Series D

Istari Oncology, Inc.: A clinical-stage biotech firm innovating in immuno-oncology for diverse tumor treatments.

HQ
Morrisville, NC, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Istari Oncology, Inc. is a clinical-stage biotechnology company founded with the mission to advance novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and various other tumors. The company's core vision is to elevate the standard of cancer care by igniting systemic anticancer responses. Istari's flagship product, Lerapolturev (formerly PVSRIPO), aims to address the limitations of current immune checkpoint inhibitors by overcoming the immunosuppressive tumor microenvironment and enhancing the presence of anticancer T cells.

Notable figures affiliated with Istari Oncology include leading scientists and industry experts in oncology and immunotherapy. The company has garnered attention from prominent investors in the biotech sector, contributing to its research and development efforts. Key achievements include advancing Lerapolturev through clinical trials and demonstrating its potential to revolutionize cancer treatment. Istari Oncology's impact lies in its innovative approach to tackling complex immune system challenges, positioning it as a promising player in the fight against cancer.

Istari Oncology - Similar Companies

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

Irazu Oncology logo

Irazu Oncology

irazuoncology.com

MaveriX Oncology logo

MaveriX Oncology

Revitope Oncology logo

Revitope Oncology

revitope.com

OncoSpherix logo

OncoSpherix

oncospherix.com

OncoResponse logo

OncoResponse

Larkspur Biosciences logo

Larkspur Biosciences

larkspur.bio

BioEclipse Therapeutics logo

BioEclipse Therapeutics

bioeclipse.com

Oncofactor logo

Oncofactor

oncofactor.com

Iovance Biotherapeutics logo

Iovance Biotherapeutics

iovance.com

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

Werewolf Therapeutics logo

Werewolf Therapeutics

werewolftx.com

OncoPrecision logo

OncoPrecision

oncoprecision.bio

NextCure logo

NextCure

nextcure.com

Aktis Oncology logo

Aktis Oncology

aktisoncology.com

Istari Oncology - Quick Facts

Who are Istari Oncology's competitors?

Companies similar to Istari Oncology include Immune-Onc Therapeutics, Irazu Oncology, MaveriX Oncology and Revitope Oncology.

When was Istari Oncology founded?

Istari Oncology was founded in 2014.

Where is Istari Oncology's headquarters located?

Istari Oncology's headquarters is located in Morrisville, NC, US.

When was Istari Oncology's last funding round?

Istari Oncology's most recent funding round was for $43.4M (USD) in April 2021.

How much has Istari Oncology raised to-date?

As of Apr 22, 2021, Istari Oncology has raised a total of $48.5M (USD).

How many employees does Istari Oncology have?

Istari Oncology has 37 employees as of Feb 5, 2024.

Istari Oncology - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatment
  • Immunotherapy
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified